S.Amdt. 1915
What it does: Adds Sec. 537. (a) None of the funds appropriated or otherwise made available by this or any other Act may be used by an executive agency to initiate, complete, or implement, under the provisions of Office of Management and Budget Circular A-76 or under any similar provisions of any other order or directive, any competitive sourcing study regarding the performance of any activity of an executive agency that relates to agency security, biodefense, or homeland security, including-- on page 127, line 23
Sen. Barbara A. Mikulski (D-MD)What it changes
1 change to H.R. 2989
Adds Sec. 537. (a) None of the funds appropriated or otherwise made available by this or any other Act may be used by an executive agency to initiate, complete, or implement, under the provisions of Office of Management and Budget Circular A-76 or under any similar provisions of any other order or directive, any competitive sourcing study regarding the performance of any activity of an executive agency that relates to agency security, biodefense, or homeland security, including-- on page 127, line 23
Adds a sectionPrinted pageInserted: Sec. 537. (a) None of the funds appropriated or otherwise made available by this or any other Act may be used by an executive agency to initiate, complete, or implement, under the provisions of Office of Management and Budget Circular A-76 or under any similar provisions of any other order or directive, any competitive sourcing study regarding the performance of any activity of an executive agency that relates to agency security, biodefense, or homeland security, including--
Inserted: (1) any research relating to infectious diseases and biomedical terrorism;
Inserted: (2) any activity requiring--
Inserted: (A) physical, electronic, or other access to biological, pathological, chemical, genetic, or radioactive substances; and
Inserted: (B) the development or documentation of such substances; and
Inserted: (3) the safeguarding and maintenance of biological, pathological, chemical, genetic, or radioactive substances and the facilities housing such substances.
Inserted: (b) Nothing in this section shall be construed to prohibit the use of funds for solicitation, review, or awarding of grants for support of research relating to biodefense or homeland security, including any such research that relates to infectious diseases or biomedical terrorism.
Inserted: (c) In this section, the term "executive agency" has the meaning given such term in section 4 of the Office of Federal Procurement Policy Act (41 U.S.C. 403).
Original wording
On page 127, after line 23, insert the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 1915. Ms. MIKULSKI submitted an amendment intended to be proposed by her to the bill H.R. 2989, making appropriations for the Departments of Transportation and Treasury, and independent agencies for the fiscal year ending September 30, 2004, and for other purposes; which was ordered to lie on the table; as follows:
On page 127, after line 23, insert the following:
Sec. 537. (a) None of the funds appropriated or otherwise made available by this or any other Act may be used by an executive agency to initiate, complete, or implement, under the provisions of Office of Management and Budget Circular A-76 or under any similar provisions of any other order or directive, any competitive sourcing study regarding the performance of any activity of an executive agency that relates to agency security, biodefense, or homeland security, including--
(1) any research relating to infectious diseases and biomedical terrorism;
(2) any activity requiring--
(A) physical, electronic, or other access to biological, pathological, chemical, genetic, or radioactive substances; and
(B) the development or documentation of such substances; and
(3) the safeguarding and maintenance of biological, pathological, chemical, genetic, or radioactive substances and the facilities housing such substances.
(b) Nothing in this section shall be construed to prohibit the use of funds for solicitation, review, or awarding of grants for support of research relating to biodefense or homeland security, including any such research that relates to infectious diseases or biomedical terrorism.
(c) In this section, the term “executive agency” has the meaning given such term in section 4 of the Office of Federal Procurement Policy Act (41 U.S.C. 403).
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
October 23, 2003